The Journal of Nuclear Medicine presents a new podcast on advances in dementia imaging. Panelists discuss the importance of amyloid and tau PET imaging in dementia diagnosis and treatment, highlighting their roles in clinical trials and future therapies. They emphasize the significance of early detection and the potential for personalized medicine approaches.
Panel: 
• Ken Herrmann, MD, MBA (Universitätsmedizin, Essen, Germany)
• Henryk Barthel, MD, PhD (Leipzig University)
• Gil Rabinovici, MD (University of California - San Francisco)
• Victor Villemagne, MD (University of Pittsburgh)